Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2021.733246
Abstract: Immune checkpoint blockade (ICB) therapies such as PD-1 antibodies have produced significant clinical responses in treating a variety of human malignancies, yet only a subset of cancer patients benefit from such therapy. To improve the…
read more here.
Keywords:
immune checkpoint;
icb therapies;
fucoidan;
supplemented diet ... See more keywords